Englander Institute for Precision Medicine

Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.

TitleAuthor Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.
Publication TypeJournal Article
Year of Publication2025
AuthorsPetroni G, Galassi C, Gouin KH, Chen H-H, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G, Jiménez-Cortegana C, Shah A, Kirchmair A, Massa C, Wickenhauser C, de Andrea CEduardo, Navarro-Rubio B, Serrano-Mendioroz I, Manzano ENavarro, Satty AM, Rippon B, Finotello F, Trajanoski Z, Zhou XKathy, Scandura JM, García-Martínez E, de la Peña FAyala, Rodriguez-Ruiz MEsperanza, Seliger B, Sánchez-Margalet V, de la Cruz-Merino L, Basho RK, Shiao SL, McArthur HL, Formenti SC, Knott SRV, Galluzzi L
JournalNat Cancer
Date Published2025 Jul 23
ISSN2662-1347
DOI10.1038/s43018-025-01036-8
Alternate JournalNat Cancer
PubMed ID40702362

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021